Prolonged gastrointestinal dysmotility in a patient with hemophagocytic lymphohistiocytosis treated with vincristine.
Tomomasa
T
T
Department of Pediatrics, Gunma University School of Medicine, Maebashi, Japan.
Miyazawa
R
R
Kato
M
M
Hoshino
M
M
Tabata
M
M
Kaneko
H
H
Suzuki
M
M
Kobayashi
T
T
Morikawa
A
A
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001464:Barium; D002648:Child; D002908:Chronic Disease; D005471:Fluoroscopy; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D005769:Gastrointestinal Motility; D005772:Gastrointestinal Transit; D015616:Histiocytosis, Non-Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007421:Intestine, Small / Q000378:metabolism; D008297:Male; D008365:Manometry; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D000972:Antineoplastic Agents, Phytogenic; D001464:Barium; D014750:Vincristine